Your browser doesn't support javascript.
loading
Can we cure refractory Hodgkin's lymphoma with transplantation?
Ciurea, Stefan O; Kongtim, Piyanuch; Srour, Samer; Saini, Neeraj; Im, Jin; Ramdial, Jeremy; Khouri, Issa; Anderlini, Paolo; Popat, Uday; Hosing, Chitra; Champlin, Richard E; Lee, Hun J; Fayad, Luis E; Hagemeister, Fredrick B; Bica, Ana M; Lipan, Lavinia; Craciun, Oana; Jercan, Cristina G; Tanase, Alina; Colita, Anca.
Afiliación
  • Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sciurea@mdanderson.org.
  • Kongtim P; Professor of Clinical Medicine, Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, 101 The City Drive South, Building 200, Room 450, ZOT 4061, Orange, CA, 92868, USA. sciurea@mdanderson.org.
  • Srour S; Center of Excellence in Applied Epidemiology and Hematopoietic Stem Cell Transplant Program, Thammasat University, Pathumthani, Thailand.
  • Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Im J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khouri I; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Anderlini P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hosing C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee HJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fayad LE; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hagemeister FB; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bica AM; Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lipan L; Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
  • Craciun O; Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
  • Jercan CG; Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
  • Tanase A; Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
  • Colita A; Bone Marrow Transplant Unit, Fundeni Clinical Institute, Bucharest, Romania.
Bone Marrow Transplant ; 56(1): 278-281, 2021 01.
Article en En | MEDLINE | ID: mdl-32636464
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Enfermedad de Hodgkin Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos